Nicholas N Ashton Selected Research

norspermidine

1/2019

In vivo analysis of a first-in-class tri-alkyl norspermidine-biaryl antibiotic in an active release coating to reduce the risk of implant-related infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas N Ashton Research Topics

Disease

2	Infections 01/2019 - 01/2019
2	Rupture 01/2016 - 03/2015

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2019
1	norspermidineIBA 01/2019
1	SiliconesIBA 01/2019
1	PhosphoserineIBA 01/2016
1	PlasticsIBA 03/2015

Therapy/Procedure

1	Therapeutics 01/2019
1	Replacement Arthroplasty 01/2019